NFA
ASPX

Nationwide Fund Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Nationwide Fund Advisors’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,815
Closed -$884K – 3447
2015
Q1 		$884K Buy
8,815
+183
+2% +$12.2K ﹤0.01% 1948
2014
Q4 		$453K Sell
8,632
-61
-0.7% -$1.79K ﹤0.01% 2235
2014
Q3 		$223K Buy
8,693
+968
+13% +$20.6K ﹤0.01% 2634
2014
Q2 		$172K Buy
7,725
+3,754
+95% +$82.1K ﹤0.01% 2823
2014
Q1 		$122K Buy
+3,971
New +$107K ﹤0.01% 2685

Nationwide Fund Advisors's ASPX Position: Q2 2015 in Review

Nationwide Fund Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 8,815 shares — an estimated $884K sold.

Nationwide Fund Advisors first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $884K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Nationwide Fund Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 8,815 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $884K.
  • Nationwide Fund Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Nationwide Fund Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $884K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.